These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30265435)

  • 1. Cardiac allograft vasculopathy: A review.
    Lee MS; Tadwalkar RV; Fearon WF; Kirtane AJ; Patel AJ; Patel CB; Ali Z; Rao SV
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E527-E536. PubMed ID: 30265435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac allograft vasculopathy.
    Lee MS; Finch W; Weisz G; Kirtane AJ
    Rev Cardiovasc Med; 2011; 12(3):143-52. PubMed ID: 22080925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience.
    Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
    Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
    Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
    Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
    Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
    JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
    Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and imaging of cardiac allograft vasculopathy.
    Pollack A; Nazif T; Mancini D; Weisz G
    JACC Cardiovasc Imaging; 2013 May; 6(5):613-23. PubMed ID: 23680373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography imaging of cardiac allograft vasculopathy.
    Ferencik M; Brady TJ; Hoffmann U
    J Cardiovasc Comput Tomogr; 2012; 6(4):223-31. PubMed ID: 22732195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac allograft vasculopathy.
    Rhodes LR
    Crit Care Nurs Q; 2004; 27(1):10-6. PubMed ID: 14974521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Sex on Outcomes Among Patients With Cardiac Allograft Vasculopathy Who Undergo Percutaneous Coronary Intervention.
    Lee MS; Wadia SK; Shlofmitz R
    J Invasive Cardiol; 2020 Dec; 32(12):453-458. PubMed ID: 33221733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early aspirin use and the development of cardiac allograft vasculopathy.
    Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
    J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.
    van Heeswijk RB; Bastiaansen JAM; Iglesias JF; Degrauwe S; Rotman S; Barras JL; Regamey J; Lauriers N; Tozzi P; Yerly J; Ginami G; Stuber M; Hullin R
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):533-542. PubMed ID: 31724114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive Imaging in the Evaluation of Cardiac Allograft Vasculopathy in Heart Transplantation: A Systematic Review.
    Ajluni SC; Mously H; Chami T; Hajjari J; Stout A; Zacharias M; ElAmm C; Wilson D; Janus SE; Al-Kindi SG
    Curr Probl Cardiol; 2022 Aug; 47(8):101103. PubMed ID: 35016989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.